THE INFLUENCE OF PACLITAXEL TREATMENT ON SELECTED BIOCHEMICAL AND MORPHOLOGICAL BLOOD PARAMETERS IN PATIENTS DIAGNOSED WITH BREAST CANCER Głowacka I., Zegarski W., Nowacka K., Trybuś H., Siedlecki Z., Beuth W., Nowacki M., Nalazek A., Trela E., Zukow W
BACKGROUND: Chemotherapy is a well-established therapeutic modality known for ages for the treatme...
PubMed ID: 25233884Purpose: Cytotoxic treatment may cause weight gain and important alterations in t...
Background Epithelial ovarian cancer (EOC) is one of the most common cancers diagnosed in Indonesian...
The vast majority of breast cancer patients have logged phenomenon of systemic toxicity during the p...
The vast majority of breast cancer patients have logged phenomenon of systemic toxicity during the p...
Background: The aim of this study was to quantitatively assess the effect of anthropometric and bioc...
The interest in studying the effect of haematological complications on survival of patients with sol...
The interest in studying the effect of haematological complications on survival of patients with sol...
To evaluate the changes in the biological features of breast cancer cells induced by primary chemoth...
<p><strong>Background:</strong> Paclitaxel and carboplatin are standard operating procedure for chem...
Objective: This study aimed to to evaluate the variation and importance of certain hematological, en...
Paclitaxel (Taxol®) is now widely used against breast, ovarian and non-small-cell lung cancer. Antic...
Breast cancer is the most frequent cancer among women around the world. Various studies have looked ...
AimsTo assess quantitatively the safety and pharmacology of paclitaxel in patients with moderate to ...
PubMed ID: 15828451The authors compare results obtained from weekly paclitaxel treatment in advanced...
BACKGROUND: Chemotherapy is a well-established therapeutic modality known for ages for the treatme...
PubMed ID: 25233884Purpose: Cytotoxic treatment may cause weight gain and important alterations in t...
Background Epithelial ovarian cancer (EOC) is one of the most common cancers diagnosed in Indonesian...
The vast majority of breast cancer patients have logged phenomenon of systemic toxicity during the p...
The vast majority of breast cancer patients have logged phenomenon of systemic toxicity during the p...
Background: The aim of this study was to quantitatively assess the effect of anthropometric and bioc...
The interest in studying the effect of haematological complications on survival of patients with sol...
The interest in studying the effect of haematological complications on survival of patients with sol...
To evaluate the changes in the biological features of breast cancer cells induced by primary chemoth...
<p><strong>Background:</strong> Paclitaxel and carboplatin are standard operating procedure for chem...
Objective: This study aimed to to evaluate the variation and importance of certain hematological, en...
Paclitaxel (Taxol®) is now widely used against breast, ovarian and non-small-cell lung cancer. Antic...
Breast cancer is the most frequent cancer among women around the world. Various studies have looked ...
AimsTo assess quantitatively the safety and pharmacology of paclitaxel in patients with moderate to ...
PubMed ID: 15828451The authors compare results obtained from weekly paclitaxel treatment in advanced...
BACKGROUND: Chemotherapy is a well-established therapeutic modality known for ages for the treatme...
PubMed ID: 25233884Purpose: Cytotoxic treatment may cause weight gain and important alterations in t...
Background Epithelial ovarian cancer (EOC) is one of the most common cancers diagnosed in Indonesian...